Symbol:
Azin1
Name:
antizyme inhibitor 1
RGD ID:
61934
Description:
Predicted to enable ornithine decarboxylase activator activity and ornithine decarboxylase activity. Involved in several processes, including estrous cycle; negative regulation of protein catabolic process; and positive regulation of centrosome duplication. Located in centrosome. Biomarker of pneumocystosis. Human ortholog(s) of this gene implicated in esophagus squamous cell carcinoma; hepatocellular carcinoma; and liver cirrhosis. Orthologous to human AZIN1 (antizyme inhibitor 1); PARTICIPATES IN polyamine metabolic pathway; INTERACTS WITH 2,3,7,8-tetrachlorodibenzodioxine; 2,4-dinitrotoluene; 2,6-dinitrotoluene.
Type:
protein-coding
RefSeq Status:
REVIEWED
Previously known as:
AZI; Oazi; Oazin; ornithine decarboxylase antizyme inhibitor
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
AZIN1 (antizyme inhibitor 1)
HGNC
EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, Treefam
Mus musculus (house mouse):
Azin1 (antizyme inhibitor 1)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chinchilla lanigera (long-tailed chinchilla):
Azin1 (antizyme inhibitor 1)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
AZIN1 (antizyme inhibitor 1)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
AZIN1 (antizyme inhibitor 1)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Azin1 (antizyme inhibitor 1)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
AZIN1 (antizyme inhibitor 1)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chlorocebus sabaeus (green monkey):
AZIN1 (antizyme inhibitor 1)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Heterocephalus glaber (naked mole-rat):
Azin1 (antizyme inhibitor 1)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Other homologs 2
Homo sapiens (human):
INTS5 (integrator complex subunit 5)
HGNC
OMA
Alliance orthologs 3
Homo sapiens (human):
AZIN1 (antizyme inhibitor 1)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Mus musculus (house mouse):
Azin1 (antizyme inhibitor 1)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
azin1a (antizyme inhibitor 1a)
Alliance
DIOPT (Ensembl Compara|OMA|OrthoFinder|PANTHER|PhylomeDB)
Danio rerio (zebrafish):
azin1b (antizyme inhibitor 1b)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Drosophila melanogaster (fruit fly):
Odc1
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Drosophila melanogaster (fruit fly):
Odc2
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoInspector|PANTHER|SonicParanoid)
Saccharomyces cerevisiae (baker's yeast):
SPE1
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|SonicParanoid)
Caenorhabditis elegans (roundworm):
odc-1
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OrthoFinder|OrthoInspector|PANTHER|SonicParanoid)
Xenopus tropicalis (tropical clawed frog):
azin1
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 7 71,539,711 - 71,566,515 (-) NCBI GRCr8 mRatBN7.2 7 69,654,773 - 69,681,578 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 7 69,654,663 - 69,681,578 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 7 71,536,617 - 71,563,437 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 7 73,739,154 - 73,765,974 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 7 73,607,179 - 73,633,999 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 7 77,345,646 - 77,372,398 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 7 77,345,646 - 77,372,398 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 7 77,448,669 - 77,475,344 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 7 74,159,130 - 74,189,447 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 7 74,179,861 - 74,210,177 (-) NCBI Celera 7 66,713,070 - 66,739,866 (-) NCBI Celera Cytogenetic Map 7 q22 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Azin1 Rat (-)-epigallocatechin 3-gallate multiple interactions ISO AZIN1 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of AZIN1 mRNA CTD PMID:22079256 Azin1 Rat (1->4)-beta-D-glucan multiple interactions ISO Azin1 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of AZIN1 mRNA CTD PMID:36331819 Azin1 Rat 1,2-dichloroethane decreases expression ISO Azin1 (Mus musculus) 6480464 ethylene dichloride results in decreased expression of AZIN1 mRNA CTD PMID:28960355 Azin1 Rat 1,2-dimethylhydrazine multiple interactions ISO Azin1 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of AZIN1 mRNA CTD PMID:22206623 Azin1 Rat 1,2-dimethylhydrazine decreases expression ISO Azin1 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of AZIN1 mRNA CTD PMID:22206623 Azin1 Rat 1-chloro-2,4-dinitrobenzene decreases expression ISO AZIN1 (Homo sapiens) 6480464 Dinitrochlorobenzene results in decreased expression of AZIN1 mRNA CTD PMID:17374397 Azin1 Rat 17alpha-ethynylestradiol increases expression ISO Azin1 (Mus musculus) 6480464 Ethinyl Estradiol results in increased expression of AZIN1 mRNA CTD PMID:17942748 Azin1 Rat 17beta-estradiol decreases expression ISO Azin1 (Mus musculus) 6480464 Estradiol results in decreased expression of AZIN1 mRNA CTD PMID:39298647 Azin1 Rat 17beta-estradiol increases expression ISO AZIN1 (Homo sapiens) 6480464 Estradiol results in increased expression of AZIN1 mRNA CTD PMID:31614463 Azin1 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of AZIN1 mRNA CTD PMID:21215274 and PMID:34747641 Azin1 Rat 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Azin1 (Mus musculus) 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of AZIN1 mRNA CTD PMID:25975270 Azin1 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Azin1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of AZIN1 mRNA CTD PMID:21570461 and PMID:28922406 Azin1 Rat 2,4-dinitrotoluene affects expression EXP 6480464 2 and 4-dinitrotoluene affects the expression of AZIN1 mRNA CTD PMID:21346803 Azin1 Rat 2,6-dinitrotoluene affects expression EXP 6480464 2 and 6-dinitrotoluene affects the expression of AZIN1 mRNA CTD PMID:21346803 Azin1 Rat 2-amino-2-deoxy-D-glucopyranose decreases expression EXP 6480464 Glucosamine results in decreased expression of AZIN1 mRNA CTD PMID:17109745 Azin1 Rat 2-amino-2-deoxy-D-glucopyranose multiple interactions EXP 6480464 IL1B promotes the reaction [Glucosamine results in increased expression of AZIN1 mRNA] CTD PMID:17109745 Azin1 Rat 2-butoxyethanol increases expression ISO Azin1 (Mus musculus) 6480464 n-butoxyethanol results in increased expression of AZIN1 mRNA CTD PMID:19812364 Azin1 Rat 3,4-methylenedioxymethamphetamine increases expression ISO Azin1 (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of AZIN1 mRNA CTD PMID:20188158 Azin1 Rat 3H-1,2-dithiole-3-thione decreases expression EXP 6480464 1 and 2-dithiol-3-thione results in decreased expression of AZIN1 mRNA CTD PMID:19162173 Azin1 Rat 4,4'-sulfonyldiphenol decreases expression ISO Azin1 (Mus musculus) 6480464 bisphenol S results in decreased expression of AZIN1 mRNA CTD PMID:33297965 and PMID:39298647 Azin1 Rat 4-(ethoxymethylene)-2-phenyloxazol-5-one decreases expression ISO AZIN1 (Homo sapiens) 6480464 Oxazolone results in decreased expression of AZIN1 mRNA CTD PMID:17374397 Azin1 Rat 4-hydroxyphenyl retinamide increases expression ISO Azin1 (Mus musculus) 6480464 Fenretinide results in increased expression of AZIN1 mRNA CTD PMID:28973697 Azin1 Rat 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of AZIN1 mRNA CTD PMID:30047161 Azin1 Rat acetamide decreases expression EXP 6480464 acetamide results in decreased expression of AZIN1 mRNA CTD PMID:31881176 Azin1 Rat acrolein multiple interactions ISO AZIN1 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of AZIN1 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of AZIN1 mRNA CTD PMID:32699268 Azin1 Rat aflatoxin B1 increases expression ISO Azin1 (Mus musculus) 6480464 Aflatoxin B1 results in increased expression of AZIN1 mRNA CTD PMID:19770486 Azin1 Rat aflatoxin B1 increases expression ISO AZIN1 (Homo sapiens) 6480464 Aflatoxin B1 results in increased expression of AZIN1 mRNA CTD PMID:27153756 Azin1 Rat aldehydo-D-glucosamine decreases expression EXP 6480464 Glucosamine results in decreased expression of AZIN1 mRNA CTD PMID:17109745 Azin1 Rat aldehydo-D-glucosamine multiple interactions EXP 6480464 IL1B promotes the reaction [Glucosamine results in increased expression of AZIN1 mRNA] CTD PMID:17109745 Azin1 Rat all-trans-retinoic acid decreases expression ISO AZIN1 (Homo sapiens) 6480464 Tretinoin results in decreased expression of AZIN1 mRNA CTD PMID:15498508 Azin1 Rat alpha-pinene multiple interactions ISO AZIN1 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of AZIN1 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of AZIN1 mRNA CTD PMID:32699268 Azin1 Rat amitrole increases expression EXP 6480464 Amitrole results in increased expression of AZIN1 mRNA CTD PMID:30047161 Azin1 Rat ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of AZIN1 mRNA CTD PMID:16483693 Azin1 Rat arsenite(3-) multiple interactions ISO AZIN1 (Homo sapiens) 6480464 arsenite inhibits the reaction [G3BP1 protein binds to AZIN1 mRNA] CTD PMID:32406909 Azin1 Rat benzo[a]pyrene affects methylation ISO AZIN1 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of AZIN1 5' UTR more ... CTD PMID:27901495 and PMID:30157460 Azin1 Rat benzo[a]pyrene diol epoxide I decreases expression ISO AZIN1 (Homo sapiens) 6480464 7 more ... CTD PMID:19150397 Azin1 Rat beta-D-glucosamine decreases expression EXP 6480464 Glucosamine results in decreased expression of AZIN1 mRNA CTD PMID:17109745 Azin1 Rat beta-D-glucosamine multiple interactions EXP 6480464 IL1B promotes the reaction [Glucosamine results in increased expression of AZIN1 mRNA] CTD PMID:17109745 Azin1 Rat beta-lapachone decreases expression ISO AZIN1 (Homo sapiens) 6480464 beta-lapachone results in decreased expression of AZIN1 mRNA CTD PMID:38218311 Azin1 Rat bisphenol A increases expression ISO AZIN1 (Homo sapiens) 6480464 bisphenol A results in increased expression of AZIN1 mRNA CTD PMID:18007998 Azin1 Rat bisphenol A multiple interactions ISO AZIN1 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of AZIN1 gene CTD PMID:31601247 Azin1 Rat bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of AZIN1 mRNA CTD PMID:25181051 and PMID:30816183 Azin1 Rat buspirone decreases expression EXP 6480464 Buspirone results in decreased expression of AZIN1 mRNA CTD PMID:24136188 Azin1 Rat cadmium atom multiple interactions ISO Azin1 (Mus musculus) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of AZIN1 mRNA CTD PMID:37325564 Azin1 Rat cadmium dichloride increases expression ISO AZIN1 (Homo sapiens) 6480464 Cadmium Chloride results in increased expression of AZIN1 mRNA CTD PMID:38568856 Azin1 Rat cadmium dichloride multiple interactions ISO Azin1 (Mus musculus) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of AZIN1 mRNA CTD PMID:37325564 Azin1 Rat cadmium sulfate decreases expression ISO Azin1 (Mus musculus) 6480464 cadmium sulfate results in decreased expression of AZIN1 mRNA CTD PMID:19274763 Azin1 Rat carbamazepine affects expression ISO AZIN1 (Homo sapiens) 6480464 Carbamazepine affects the expression of AZIN1 mRNA CTD PMID:24752500 and PMID:25979313 Azin1 Rat carbon nanotube decreases expression ISO Azin1 (Mus musculus) 6480464 Nanotubes and Carbon results in decreased expression of AZIN1 mRNA CTD PMID:25620056 Azin1 Rat carbon nanotube increases expression ISO Azin1 (Mus musculus) 6480464 Nanotubes and Carbon results in increased expression of AZIN1 mRNA CTD PMID:25554681 Azin1 Rat choline multiple interactions ISO Azin1 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of AZIN1 gene CTD PMID:20938992 Azin1 Rat chromium(6+) multiple interactions ISO AZIN1 (Homo sapiens) 6480464 [zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of AZIN1 mRNA CTD PMID:38479592 Azin1 Rat cisplatin multiple interactions ISO AZIN1 (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of AZIN1 mRNA CTD PMID:27392435 Azin1 Rat cobalt dichloride increases expression ISO AZIN1 (Homo sapiens) 6480464 cobaltous chloride results in increased expression of AZIN1 mRNA CTD PMID:19376846 Azin1 Rat copper(II) sulfate increases expression ISO AZIN1 (Homo sapiens) 6480464 Copper Sulfate results in increased expression of AZIN1 mRNA CTD PMID:19549813 Azin1 Rat coumarin increases phosphorylation ISO AZIN1 (Homo sapiens) 6480464 coumarin results in increased phosphorylation of AZIN1 protein CTD PMID:35688186 Azin1 Rat cyclosporin A increases expression ISO AZIN1 (Homo sapiens) 6480464 Cyclosporine results in increased expression of AZIN1 mRNA CTD PMID:20106945 and PMID:25562108 Azin1 Rat Dibutyl phosphate affects expression ISO AZIN1 (Homo sapiens) 6480464 di-n-butylphosphoric acid affects the expression of AZIN1 mRNA CTD PMID:37042841 Azin1 Rat dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of AZIN1 mRNA CTD PMID:21266533 Azin1 Rat dibutyl phthalate increases expression ISO Azin1 (Mus musculus) 6480464 Dibutyl Phthalate results in increased expression of AZIN1 mRNA CTD PMID:17361019 and PMID:21266533 Azin1 Rat diclofenac affects expression ISO AZIN1 (Homo sapiens) 6480464 Diclofenac affects the expression of AZIN1 mRNA CTD PMID:24752500 Azin1 Rat dioxygen multiple interactions ISO Azin1 (Mus musculus) 6480464 Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of AZIN1 mRNA] CTD PMID:22629407 Azin1 Rat dioxygen increases expression ISO Azin1 (Mus musculus) 6480464 Oxygen deficiency results in increased expression of AZIN1 mRNA CTD PMID:22629407 Azin1 Rat doxorubicin increases expression ISO Azin1 (Mus musculus) 6480464 Doxorubicin results in increased expression of AZIN1 mRNA CTD PMID:22016648 Azin1 Rat doxorubicin increases expression ISO AZIN1 (Homo sapiens) 6480464 Doxorubicin results in increased expression of AZIN1 mRNA CTD PMID:29803840 Azin1 Rat endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of AZIN1 mRNA CTD PMID:29391264 Azin1 Rat epoxiconazole decreases expression ISO Azin1 (Mus musculus) 6480464 epoxiconazole results in decreased expression of AZIN1 mRNA CTD PMID:35436446 Azin1 Rat ethanol affects expression ISO Azin1 (Mus musculus) 6480464 Ethanol affects the expression of AZIN1 mRNA CTD PMID:30319688 Azin1 Rat flutamide increases expression EXP 6480464 Flutamide results in increased expression of AZIN1 mRNA CTD PMID:24136188 Azin1 Rat folic acid multiple interactions ISO Azin1 (Mus musculus) 6480464 [1 more ... CTD PMID:20938992 and PMID:22206623 Azin1 Rat fulvestrant multiple interactions ISO AZIN1 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of AZIN1 gene CTD PMID:31601247 Azin1 Rat gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of AZIN1 mRNA CTD PMID:33387578 Azin1 Rat graphite affects expression EXP 6480464 Graphite affects the expression of AZIN1 mRNA CTD PMID:29933104 Azin1 Rat L-methionine multiple interactions ISO Azin1 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of AZIN1 gene CTD PMID:20938992 Azin1 Rat methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of AZIN1 mRNA CTD PMID:16393664 and PMID:30467583 Azin1 Rat methimazole increases expression EXP 6480464 Methimazole results in increased expression of AZIN1 mRNA CTD PMID:30047161 Azin1 Rat N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine increases expression ISO AZIN1 (Homo sapiens) 6480464 N more ... CTD PMID:12756304 Azin1 Rat nefazodone increases expression EXP 6480464 nefazodone results in increased expression of AZIN1 mRNA CTD PMID:24136188 Azin1 Rat nickel subsulfide increases expression EXP 6480464 nickel subsulfide results in increased expression of AZIN1 mRNA CTD PMID:21086188 Azin1 Rat nickel sulfate decreases expression ISO AZIN1 (Homo sapiens) 6480464 nickel sulfate results in decreased expression of AZIN1 mRNA CTD PMID:17374397 Azin1 Rat ozone multiple interactions ISO AZIN1 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of AZIN1 mRNA more ... CTD PMID:32699268 and PMID:35430440 Azin1 Rat ozone increases expression EXP 6480464 Ozone results in increased expression of AZIN1 mRNA CTD PMID:35737395 Azin1 Rat ozone multiple interactions ISO Azin1 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of Ozone] which results in increased expression of AZIN1 mRNA CTD PMID:34911549 Azin1 Rat paracetamol affects expression ISO Azin1 (Mus musculus) 6480464 Acetaminophen affects the expression of AZIN1 mRNA CTD PMID:17562736 Azin1 Rat paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of AZIN1 mRNA CTD PMID:33387578 Azin1 Rat paracetamol decreases expression ISO Azin1 (Mus musculus) 6480464 Acetaminophen results in decreased expression of AZIN1 mRNA CTD PMID:11264010 Azin1 Rat perfluorooctane-1-sulfonic acid multiple interactions ISO Azin1 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of AZIN1 mRNA CTD PMID:36331819 Azin1 Rat perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of AZIN1 mRNA CTD PMID:19162173 Azin1 Rat phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of AZIN1 mRNA CTD PMID:19162173 Azin1 Rat phenobarbital affects expression ISO AZIN1 (Homo sapiens) 6480464 Phenobarbital affects the expression of AZIN1 mRNA CTD PMID:19159669 Azin1 Rat phenobarbital increases expression ISO Azin1 (Mus musculus) 6480464 Phenobarbital results in increased expression of AZIN1 mRNA CTD PMID:19270015 Azin1 Rat pirinixic acid multiple interactions ISO AZIN1 (Homo sapiens) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of AZIN1 mRNA CTD PMID:19710929 Azin1 Rat pirinixic acid decreases expression ISO Azin1 (Mus musculus) 6480464 pirinixic acid results in decreased expression of AZIN1 mRNA CTD PMID:18445702 and PMID:23811191 Azin1 Rat pirinixic acid increases expression ISO Azin1 (Mus musculus) 6480464 pirinixic acid results in increased expression of AZIN1 mRNA CTD PMID:18301758 Azin1 Rat potassium chromate multiple interactions ISO AZIN1 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of AZIN1 mRNA CTD PMID:22079256 Azin1 Rat potassium chromate increases expression ISO AZIN1 (Homo sapiens) 6480464 potassium chromate(VI) results in increased expression of AZIN1 mRNA CTD PMID:22079256 Azin1 Rat potassium dichromate decreases expression ISO Azin1 (Mus musculus) 6480464 Potassium Dichromate results in decreased expression of AZIN1 mRNA CTD PMID:23608068 Azin1 Rat resveratrol multiple interactions ISO AZIN1 (Homo sapiens) 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of AZIN1 mRNA CTD PMID:23557933 Azin1 Rat S-butyl-DL-homocysteine (S,R)-sulfoximine decreases expression ISO Azin1 (Mus musculus) 6480464 Buthionine Sulfoximine results in decreased expression of AZIN1 mRNA CTD PMID:15878706 Azin1 Rat silicon dioxide decreases expression ISO AZIN1 (Homo sapiens) 6480464 Silicon Dioxide results in decreased expression of AZIN1 mRNA CTD PMID:25351596 Azin1 Rat silver atom increases expression ISO AZIN1 (Homo sapiens) 6480464 Silver results in increased expression of AZIN1 mRNA CTD PMID:26014281 Azin1 Rat silver(0) increases expression ISO AZIN1 (Homo sapiens) 6480464 Silver results in increased expression of AZIN1 mRNA CTD PMID:26014281 Azin1 Rat sodium arsenite increases expression ISO AZIN1 (Homo sapiens) 6480464 sodium arsenite results in increased expression of AZIN1 mRNA CTD PMID:38568856 Azin1 Rat sulfadimethoxine increases expression EXP 6480464 Sulfadimethoxine results in increased expression of AZIN1 mRNA CTD PMID:30047161 Azin1 Rat sulfasalazine increases expression ISO Azin1 (Mus musculus) 6480464 Sulfasalazine results in increased expression of AZIN1 mRNA CTD PMID:22016648 Azin1 Rat sunitinib decreases expression ISO AZIN1 (Homo sapiens) 6480464 Sunitinib results in decreased expression of AZIN1 mRNA CTD PMID:31533062 Azin1 Rat tamibarotene affects expression ISO AZIN1 (Homo sapiens) 6480464 tamibarotene affects the expression of AZIN1 mRNA CTD PMID:15498508 Azin1 Rat tamoxifen affects expression ISO AZIN1 (Homo sapiens) 6480464 Tamoxifen affects the expression of AZIN1 mRNA CTD PMID:14699072 Azin1 Rat tert-butyl hydroperoxide decreases expression ISO AZIN1 (Homo sapiens) 6480464 tert-Butylhydroperoxide results in decreased expression of AZIN1 mRNA CTD PMID:15336504 Azin1 Rat tetraphene affects expression ISO Azin1 (Mus musculus) 6480464 benz(a)anthracene affects the expression of AZIN1 mRNA CTD PMID:26377693 Azin1 Rat titanium dioxide affects expression ISO Azin1 (Mus musculus) 6480464 titanium dioxide affects the expression of AZIN1 mRNA CTD PMID:23557971 Azin1 Rat titanium dioxide decreases methylation ISO Azin1 (Mus musculus) 6480464 titanium dioxide results in decreased methylation of AZIN1 gene CTD PMID:35295148 Azin1 Rat titanium dioxide increases methylation ISO Azin1 (Mus musculus) 6480464 titanium dioxide results in increased methylation of AZIN1 gene CTD PMID:35295148 Azin1 Rat valproic acid decreases expression ISO Azin1 (Mus musculus) 6480464 Valproic Acid analog results in decreased expression of AZIN1 mRNA and Valproic Acid results in decreased expression of AZIN1 mRNA CTD PMID:21427059 Azin1 Rat valproic acid affects expression ISO AZIN1 (Homo sapiens) 6480464 Valproic Acid affects the expression of AZIN1 mRNA CTD PMID:25979313 Azin1 Rat valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of AZIN1 mRNA CTD PMID:23665938 Azin1 Rat valproic acid increases expression ISO Azin1 (Mus musculus) 6480464 Valproic Acid results in increased expression of AZIN1 mRNA CTD PMID:21427059 Azin1 Rat zinc atom multiple interactions ISO AZIN1 (Homo sapiens) 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of AZIN1 mRNA CTD PMID:18593933 Azin1 Rat zinc(0) multiple interactions ISO AZIN1 (Homo sapiens) 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of AZIN1 mRNA CTD PMID:18593933
(-)-epigallocatechin 3-gallate (ISO) (1->4)-beta-D-glucan (ISO) 1,2-dichloroethane (ISO) 1,2-dimethylhydrazine (ISO) 1-chloro-2,4-dinitrobenzene (ISO) 17alpha-ethynylestradiol (ISO) 17beta-estradiol (ISO) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 2,4-dinitrotoluene (EXP) 2,6-dinitrotoluene (EXP) 2-amino-2-deoxy-D-glucopyranose (EXP) 2-butoxyethanol (ISO) 3,4-methylenedioxymethamphetamine (ISO) 3H-1,2-dithiole-3-thione (EXP) 4,4'-sulfonyldiphenol (ISO) 4-(ethoxymethylene)-2-phenyloxazol-5-one (ISO) 4-hydroxyphenyl retinamide (ISO) 6-propyl-2-thiouracil (EXP) acetamide (EXP) acrolein (ISO) aflatoxin B1 (ISO) aldehydo-D-glucosamine (EXP) all-trans-retinoic acid (ISO) alpha-pinene (ISO) amitrole (EXP) ammonium chloride (EXP) arsenite(3-) (ISO) benzo[a]pyrene (ISO) benzo[a]pyrene diol epoxide I (ISO) beta-D-glucosamine (EXP) beta-lapachone (ISO) bisphenol A (EXP,ISO) buspirone (EXP) cadmium atom (ISO) cadmium dichloride (ISO) cadmium sulfate (ISO) carbamazepine (ISO) carbon nanotube (ISO) choline (ISO) chromium(6+) (ISO) cisplatin (ISO) cobalt dichloride (ISO) copper(II) sulfate (ISO) coumarin (ISO) cyclosporin A (ISO) Dibutyl phosphate (ISO) dibutyl phthalate (EXP,ISO) diclofenac (ISO) dioxygen (ISO) doxorubicin (ISO) endosulfan (EXP) epoxiconazole (ISO) ethanol (ISO) flutamide (EXP) folic acid (ISO) fulvestrant (ISO) gentamycin (EXP) graphite (EXP) L-methionine (ISO) methapyrilene (EXP) methimazole (EXP) N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine (ISO) nefazodone (EXP) nickel subsulfide (EXP) nickel sulfate (ISO) ozone (EXP,ISO) paracetamol (EXP,ISO) perfluorooctane-1-sulfonic acid (ISO) perfluorooctanoic acid (EXP) phenobarbital (EXP,ISO) pirinixic acid (ISO) potassium chromate (ISO) potassium dichromate (ISO) resveratrol (ISO) S-butyl-DL-homocysteine (S,R)-sulfoximine (ISO) silicon dioxide (ISO) silver atom (ISO) silver(0) (ISO) sodium arsenite (ISO) sulfadimethoxine (EXP) sulfasalazine (ISO) sunitinib (ISO) tamibarotene (ISO) tamoxifen (ISO) tert-butyl hydroperoxide (ISO) tetraphene (ISO) titanium dioxide (ISO) valproic acid (EXP,ISO) zinc atom (ISO) zinc(0) (ISO)
1.
Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma.
Chen L, etal., Nat Med. 2013 Feb;19(2):209-16. doi: 10.1038/nm.3043. Epub 2013 Jan 6.
2.
Expression of ODC1, SPD, SPM and AZIN1 in the hypothalamus, ovary and uterus during rat estrous cycle.
Fernandes JRD, etal., Gen Comp Endocrinol. 2017 May 15;246:9-22. doi: 10.1016/j.ygcen.2017.03.005. Epub 2017 Mar 16.
3.
Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.
Gaudet P, etal., Brief Bioinform. 2011 Sep;12(5):449-62. doi: 10.1093/bib/bbr042. Epub 2011 Aug 27.
4.
Rat ISS GO annotations from GOA human gene data--August 2006
GOA data from the GO Consortium
5.
Regulation of cell proliferation by the antizyme inhibitor: evidence for an antizyme-independent mechanism.
Kim SW, etal., J Cell Sci. 2006 Jun 15;119(Pt 12):2583-91. doi: 10.1242/jcs.02966. Epub 2006 May 30.
6.
Cloning and sequencing of a human cDNA encoding ornithine decarboxylase antizyme inhibitor.
Koguchi K, etal., Biochim Biophys Acta 1997 Sep 12;1353(3):209-16.
7.
Pneumocystis mediates overexpression of antizyme inhibitor resulting in increased polyamine levels and apoptosis in alveolar macrophages.
Liao CP, etal., J Biol Chem. 2009 Mar 20;284(12):8174-84. doi: 10.1074/jbc.M805787200. Epub 2009 Jan 20.
8.
Antizyme, a mediator of ubiquitin-independent proteasomal degradation and its inhibitor localize to centrosomes and modulate centriole amplification.
Mangold U, etal., Oncogene. 2008 Jan 24;27(5):604-13. doi: 10.1038/sj.onc.1210685. Epub 2007 Jul 30.
9.
Rat ISS GO annotations from MGI mouse gene data--August 2006
MGD data from the GO Consortium
10.
Cloning of antizyme inhibitor, a highly homologous protein to ornithine decarboxylase.
Murakami Y, etal., J Biol Chem 1996 Feb 16;271(7):3340-2.
11.
Electronic Transfer of LocusLink and RefSeq Data
NCBI rat LocusLink and RefSeq merged data July 26, 2002
12.
Enhanced AZIN1 RNA editing and overexpression of its regulatory enzyme ADAR1 are important prognostic biomarkers in gastric cancer.
Okugawa Y, etal., J Transl Med. 2018 Dec 18;16(1):366. doi: 10.1186/s12967-018-1740-z.
13.
Evidence of a role for antizyme and antizyme inhibitor as regulators of human cancer.
Olsen RR and Zetter BR, Mol Cancer Res. 2011 Oct;9(10):1285-93. doi: 10.1158/1541-7786.MCR-11-0178. Epub 2011 Aug 17.
14.
[Polymorphism of ornithine decarboxylase antizyme inhibitor 1 gene is associated with liver cirrhosis in Chinese hepatitis B patients].
Peng LJ, etal., Zhonghua Gan Zang Bing Za Zhi. 2011 Mar;19(3):169-73. doi: 10.3760/cma.j.issn.1007-3418.2011.03.005.
15.
Adenosine-to-inosine RNA editing mediated by ADARs in esophageal squamous cell carcinoma.
Qin YR, etal., Cancer Res. 2014 Feb 1;74(3):840-51. doi: 10.1158/0008-5472.CAN-13-2545. Epub 2013 Dec 3.
16.
GOA pipeline
RGD automated data pipeline
17.
ClinVar Automated Import and Annotation Pipeline
RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
18.
Data Import for Chemical-Gene Interactions
RGD automated import pipeline for gene-chemical interactions
19.
AZIN1 RNA editing confers cancer stemness and enhances oncogenic potential in colorectal cancer.
Shigeyasu K, etal., JCI Insight. 2018 Jun 21;3(12). pii: 99976. doi: 10.1172/jci.insight.99976. eCollection 2018 Jun 21.
20.
Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.
Strausberg RL, etal., Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):16899-903. Epub 2002 Dec 11.
21.
Pancreatic Kininogenase Ameliorates Renal Fibrosis in Streptozotocin Induced-Diabetic Nephropathy Rat.
Zhu D, etal., Kidney Blood Press Res. 2016;41(1):9-17. doi: 10.1159/000368542. Epub 2016 Jan 8.
Azin1 (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 7 71,539,711 - 71,566,515 (-) NCBI GRCr8 mRatBN7.2 7 69,654,773 - 69,681,578 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 7 69,654,663 - 69,681,578 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 7 71,536,617 - 71,563,437 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 7 73,739,154 - 73,765,974 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 7 73,607,179 - 73,633,999 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 7 77,345,646 - 77,372,398 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 7 77,345,646 - 77,372,398 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 7 77,448,669 - 77,475,344 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 7 74,159,130 - 74,189,447 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 7 74,179,861 - 74,210,177 (-) NCBI Celera 7 66,713,070 - 66,739,866 (-) NCBI Celera Cytogenetic Map 7 q22 NCBI
AZIN1 (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 8 102,826,302 - 102,864,200 (-) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 8 102,826,111 - 102,893,864 (-) Ensembl GRCh38 hg38 GRCh38 GRCh37 8 103,838,530 - 103,876,428 (-) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 8 103,907,712 - 103,945,573 (-) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 8 103,909,226 - 103,945,551 NCBI Celera 8 100,025,705 - 100,063,568 (-) NCBI Celera Cytogenetic Map 8 q22.3 NCBI HuRef 8 99,039,532 - 99,077,262 (-) NCBI HuRef CHM1_1 8 103,878,803 - 103,916,656 (-) NCBI CHM1_1 T2T-CHM13v2.0 8 103,954,549 - 103,992,441 (-) NCBI T2T-CHM13v2.0
Azin1 (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 15 38,487,674 - 38,523,506 (-) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 15 38,487,671 - 38,519,510 (-) Ensembl GRCm39 Ensembl GRCm38 15 38,487,430 - 38,519,294 (-) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 15 38,487,427 - 38,519,266 (-) Ensembl GRCm38 mm10 GRCm38 MGSCv37 15 38,417,185 - 38,449,021 (-) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 15 38,432,019 - 38,463,855 (-) NCBI MGSCv36 mm8 Celera 15 39,113,891 - 39,145,734 (-) NCBI Celera Cytogenetic Map 15 B3.1 NCBI cM Map 15 15.17 NCBI
Azin1 (Chinchilla lanigera - long-tailed chinchilla)
Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955417 27,231,696 - 27,259,564 (-) Ensembl ChiLan1.0 ChiLan1.0 NW_004955417 27,231,695 - 27,259,564 (-) NCBI ChiLan1.0 ChiLan1.0
AZIN1 (Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 7 120,193,169 - 120,231,424 (-) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 8 95,729,217 - 95,767,340 (-) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 8 99,483,027 - 99,521,151 (-) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 8 101,639,950 - 101,678,604 (-) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 8 101,639,950 - 101,678,604 (-) Ensembl panpan1.1 panPan2
AZIN1 (Canis lupus familiaris - dog)
Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 13 4,363,996 - 4,396,069 (-) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 13 4,361,340 - 4,396,040 (-) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 13 4,364,236 - 4,396,246 (-) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 13 4,523,489 - 4,555,507 (-) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 13 4,523,405 - 4,555,498 (-) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 13 4,365,307 - 4,397,317 (-) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 13 4,482,535 - 4,514,517 (-) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 13 4,495,739 - 4,527,724 (-) NCBI UU_Cfam_GSD_1.0
Azin1 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024405303 33,375,842 - 33,406,444 (+) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936470 40,801,943 - 40,834,003 (+) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936470 40,801,943 - 40,832,543 (+) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
AZIN1 (Sus scrofa - pig)
Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 4 34,234,679 - 34,257,134 (+) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 4 34,221,368 - 34,257,261 (+) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 4 37,079,181 - 37,109,691 (+) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
AZIN1 (Chlorocebus sabaeus - green monkey)
Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 8 97,679,775 - 97,717,486 (-) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 8 97,679,468 - 97,696,928 (-) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666039 42,881,918 - 42,921,274 (+) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Azin1 (Heterocephalus glaber - naked mole-rat)
.
Predicted Target Of
Count of predictions: 406 Count of miRNA genes: 215 Interacting mature miRNAs: 273 Transcripts: ENSRNOT00000007999 Prediction methods: Microtar, Miranda, Targetscan Result types: miRGate_prediction
1300179 Kidm5 Kidney mass QTL 5 3.51 kidney mass (VT:0002707) left kidney wet weight (CMO:0000083) 7 43747012 135012528 Rat 2293667 Bss42 Bone structure and strength QTL 42 7.25 0.0001 lumbar vertebra size trait (VT:0010518) lumbar vertebra cross-sectional area (CMO:0001689) 7 47651439 92651439 Rat 10053722 Scort27 Serum corticosterone level QTL 27 2.41 0.0083 blood corticosterone amount (VT:0005345) plasma corticosterone level (CMO:0001173) 7 43228750 88228750 Rat 1549840 Bss5 Bone structure and strength QTL 5 9.8 femur strength trait (VT:0010010) femur midshaft polar moment of inertia (CMO:0001669) 7 24751841 69751841 Rat 2317035 Aia16 Adjuvant induced arthritis QTL 16 2.71 joint integrity trait (VT:0010548) right rear ankle joint diameter (CMO:0002150) 7 59238038 104238038 Rat 1300127 Srn1 Serum renin concentration QTL 1 3.87 blood renin amount (VT:0003349) plasma renin activity level (CMO:0000116) 7 29409683 84928080 Rat 2293678 Bss24 Bone structure and strength QTL 24 6.71 0.0001 femur morphology trait (VT:0000559) femur cross-sectional area (CMO:0001661) 7 47651439 92651439 Rat 1358361 Sradr5 Stress Responsive Adrenal Weight QTL 5 5.55 adrenal gland mass (VT:0010420) both adrenal glands wet weight (CMO:0000164) 7 43747012 108555253 Rat 631513 Scl7 Serum cholesterol level QTL 7 4.1 blood cholesterol amount (VT:0000180) serum total cholesterol level (CMO:0000363) 7 37960569 82960569 Rat 2293685 Bmd21 Bone mineral density QTL 21 4.2 0.0003 femur mineral mass (VT:0010011) total volumetric bone mineral density (CMO:0001728) 7 47651439 92651439 Rat 10755453 Coatc12 Coat color QTL 12 0 coat/hair pigmentation trait (VT:0010463) pigmented ventral coat/hair area to total ventral coat/hair area ratio (CMO:0001812) 7 31112832 76112832 Rat 631504 Cm27 Cardiac mass QTL 27 3.45 heart left ventricle mass (VT:0007031) heart left ventricle wet weight (CMO:0000071) 7 44421311 118198041 Rat 70173 Niddm19 Non-insulin dependent diabetes mellitus QTL 19 4.33 0.00005 blood glucose amount (VT:0000188) blood glucose level area under curve (AUC) (CMO:0000350) 7 64002457 135012528 Rat 634326 Hc3 Hypercalciuria QTL 3 2.1 urine calcium amount (VT:0002985) urine calcium excretion rate (CMO:0000763) 7 42787314 87787314 Rat 2293696 Bmd32 Bone mineral density QTL 32 5.1 0.0001 femur strength trait (VT:0010010) femoral neck polar moment of inertia (CMO:0001670) 7 47651439 92651439 Rat 7411605 Foco14 Food consumption QTL 14 24.1 0.001 eating behavior trait (VT:0001431) feed conversion ratio (CMO:0001312) 7 34293282 79293282 Rat 1300151 Bp181 Blood pressure QTL 181 3.36 arterial blood pressure trait (VT:2000000) diastolic blood pressure (CMO:0000005) 7 53612714 103945643 Rat 1559283 Emca4 Estrogen-induced mammary cancer QTL 4 3.7 mammary gland integrity trait (VT:0010552) percentage of study population developing mammary tumors during a period of time (CMO:0000948) 7 62004452 101773158 Rat 1643004 Pain2 Pain QTL 2 1 mechanical nociception trait (VT:0002734) self mutilation severity score (CMO:0002145) 7 9462246 98011544 Rat 738030 Anxrr8 Anxiety related response QTL 8 4.1 exploratory behavior trait (VT:0010471) number of entries into a discrete space in an experimental apparatus (CMO:0000960) 7 46590070 91590070 Rat 1300149 Cm6 Cardiac mass QTL 6 4.09 heart mass (VT:0007028) heart left ventricle weight to body weight ratio (CMO:0000530) 7 43747099 102228765 Rat 631534 Lnnr1 Liver neoplastic nodule remodeling QTL 1 3.85 0.001 liver integrity trait (VT:0010547) liver remodeling tumorous lesion number to liver total tumorous lesion number ratio (CMO:0001705) 7 34293282 79293282 Rat 634336 Anxrr17 Anxiety related response QTL 17 3.66 locomotor behavior trait (VT:0001392) number of entries into a discrete space in an experimental apparatus (CMO:0000960) 7 924703 115097879 Rat 2293707 Bss32 Bone structure and strength QTL 32 7.64 0.0001 femur strength trait (VT:0010010) femur midshaft polar moment of inertia (CMO:0001669) 7 47651439 92651439 Rat 61357 Bp38 Blood pressure QTL 38 1.6 0.052 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 7 41333674 119109060 Rat 2293644 Bmd29 Bone mineral density QTL 29 5.4 0.0001 femur size trait (VT:1000369) femoral neck cross-sectional area (CMO:0001697) 7 47651439 92651439 Rat 2316947 Rf58 Renal function QTL 58 7.8 kidney glomerulus morphology trait (VT:0005325) index of glomerular damage (CMO:0001135) 7 68938720 113886318 Rat 2300178 Bmd54 Bone mineral density QTL 54 5.3 0.0001 femur mineral mass (VT:0010011) volumetric bone mineral density (CMO:0001553) 7 47651439 92651439 Rat 1298528 Bp169 Blood pressure QTL 169 0.0001 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 7 61074194 106074194 Rat 61428 Scl3 Serum cholesterol level QTL 3 3.2 blood cholesterol amount (VT:0000180) serum total cholesterol level (CMO:0000363) 7 44867533 89867533 Rat 1300132 Bp182 Blood pressure QTL 182 3.49 arterial blood pressure trait (VT:2000000) blood pressure time series experimental set point of the baroreceptor response (CMO:0002593) 7 19654317 84928080 Rat 1576303 Ept7 Estrogen-induced pituitary tumorigenesis QTL 7 3.7 pituitary gland mass (VT:0010496) pituitary gland wet weight (CMO:0000853) 7 62004452 101773158 Rat 2316955 Stl24 Serum triglyceride level QTL 24 7.1 blood triglyceride amount (VT:0002644) plasma triglyceride level (CMO:0000548) 7 68938720 113886318 Rat 10402855 Bp379 Blood pressure QTL 379 0.21 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 7 29409683 74409683 Rat 2316952 Pur22 Proteinuria QTL 22 5.2 urine protein amount (VT:0005160) urine protein level (CMO:0000591) 7 68938720 113886318 Rat
A001V45
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 7 69,656,097 - 69,656,204 (+) MAPPER mRatBN7.2 Rnor_6.0 7 77,346,971 - 77,347,077 NCBI Rnor6.0 Rnor_5.0 7 77,449,969 - 77,450,075 UniSTS Rnor5.0 RGSC_v3.4 7 74,160,426 - 74,160,532 UniSTS RGSC3.4 Celera 7 66,714,395 - 66,714,501 UniSTS Cytogenetic Map 7 q22 UniSTS
WI-9274
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 15 48,855,525 - 48,855,642 (+) MAPPER mRatBN7.2 mRatBN7.2 7 69,655,461 - 69,655,578 (+) MAPPER mRatBN7.2 Rnor_6.0 7 77,346,335 - 77,346,451 NCBI Rnor6.0 Rnor_6.0 15 55,565,025 - 55,565,141 NCBI Rnor6.0 Rnor_5.0 7 77,449,333 - 77,449,449 UniSTS Rnor5.0 Rnor_5.0 15 59,286,894 - 59,287,010 UniSTS Rnor5.0 RGSC_v3.4 7 74,159,790 - 74,159,906 UniSTS RGSC3.4 RGSC_v3.4 15 54,317,220 - 54,317,336 UniSTS RGSC3.4 Celera 7 66,713,759 - 66,713,875 UniSTS Cytogenetic Map 7 q22 UniSTS
RH143277
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 7 69,680,631 - 69,680,771 (+) MAPPER mRatBN7.2 Rnor_6.0 7 77,371,453 - 77,371,592 NCBI Rnor6.0 Rnor_5.0 7 77,474,451 - 77,474,590 UniSTS Rnor5.0 RGSC_v3.4 7 74,188,553 - 74,188,692 UniSTS RGSC3.4 Celera 7 66,738,920 - 66,739,059 UniSTS RH 3.4 Map 7 633.7 UniSTS Cytogenetic Map 7 q22 UniSTS
RH140733
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 15 48,855,193 - 48,855,329 (+) MAPPER mRatBN7.2 mRatBN7.2 7 69,655,122 - 69,655,265 (+) MAPPER mRatBN7.2 Rnor_6.0 7 77,345,996 - 77,346,138 NCBI Rnor6.0 Rnor_6.0 15 55,564,686 - 55,564,828 NCBI Rnor6.0 Rnor_5.0 7 77,448,994 - 77,449,136 UniSTS Rnor5.0 Rnor_5.0 15 59,286,555 - 59,286,697 UniSTS Rnor5.0 RGSC_v3.4 7 74,159,451 - 74,159,593 UniSTS RGSC3.4 Celera 7 66,713,420 - 66,713,562 UniSTS RH 3.4 Map 7 633.3 UniSTS Cytogenetic Map 7 q22 UniSTS
G19701
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 7 69,656,097 - 69,656,204 (+) MAPPER mRatBN7.2 Rnor_6.0 7 77,346,971 - 77,347,077 NCBI Rnor6.0 Rnor_5.0 7 77,449,969 - 77,450,075 UniSTS Rnor5.0 RGSC_v3.4 7 74,160,426 - 74,160,532 UniSTS RGSC3.4 Celera 7 66,714,395 - 66,714,501 UniSTS Cytogenetic Map 7 q22 UniSTS
Azin1
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 7 69,658,063 - 69,659,554 (+) MAPPER mRatBN7.2 Rnor_6.0 7 77,348,937 - 77,350,427 NCBI Rnor6.0 Rnor_5.0 7 77,451,935 - 77,453,425 UniSTS Rnor5.0 Celera 7 66,716,361 - 66,717,851 UniSTS Cytogenetic Map 7 q22 UniSTS
Azin1rgdv877215464-A
Rat Assembly Chr Position (strand) Source JBrowse Rnor_6.0 7 77,371,405 - 77,371,405 (+) RGD Rnor6.0
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
11
49
113
91
90
59
25
59
6
218
97
93
45
60
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000007999 ⟹ ENSRNOP00000007999
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 7 69,654,773 - 69,681,578 (-) Ensembl Rnor_6.0 Ensembl 7 77,345,646 - 77,372,398 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000079644 ⟹ ENSRNOP00000069785
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 7 69,654,663 - 69,681,542 (-) Ensembl Rnor_6.0 Ensembl 7 77,345,646 - 77,372,398 (-) Ensembl
RefSeq Acc Id:
NM_001301702 ⟹ NP_001288631
RefSeq Status:
REVIEWED
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 7 71,539,711 - 71,566,515 (-) NCBI mRatBN7.2 7 69,654,773 - 69,681,578 (-) NCBI Rnor_6.0 7 77,345,646 - 77,372,398 (-) NCBI Celera 7 66,713,070 - 66,739,866 (-) NCBI
Sequence:
AATATAAATACTGGCGTCTCCGGCGCCGCCTTCCCACACTCTCTGGCTCAACTCTCGGCCGCGGTGTTTCCGTTTCTCTCCCTGGTTGTCGCCTGCTCTGCTCTTCTCATCCTTCTCGCTCTGCTGCT CTGCGGAGTGACGAGGCTGAATCTTCTCCCCACCCAGTTCGCGCTTTTCTTCTTTTTCTCGCGCCGCTCCATTTCTCCAGTCCGGCTGCCGCCGCCACTGCTGCTCAGCTGGTGTCGGTGCCGCGCGT TTCCCCCACGTCGTCCCCGCAGCCTATGGCCCAGGCCGCCTTGGGTATTTCTGCTCAAGGTAACCACATCCCTCTTTAAAAATTCCGCCGAAAAAGAGAAGACGCTTTACCCGACTCTTTGGGCCGTT ATCTCACGGCGAACTTTCTGACCGAGTATACAACTACCCAGAAGGCCTAGGAGAAGTGCTGTATAGAGAGCAGTTCGATTTTAACGCTGAGCCACCTTGGGAACCTAGCTGATGATAGGGGGGTTCCA TCTCCTAACTTGTCCATTTTGTTGCATATTCTAAGGACCCAGACATAGGCTTGGTGGCCCGTCTCTTGTTTTTCCTGGTTTATGACTTTCGGCTTTGTGGAATACGGCTGAGATGAAAGGATTTATTG ACGATGCAAACTACTCCGTTGGCCTGTTGGATGAAGGAACAAACCTTGGAAATGTTATTGATAACTATGTTTATGAACATACCCTGACAGGAAAAAATGCATTTTTTGTGGGGGATCTTGGGAAGATC GTGAAGAAGCACAGTCAGTGGCAGAACGTGGTGGCTCAGATAAAGCCATTTTACATGGTGAAGTGCAACTCCACTCCAGCCGTACTGGAGATCTTGGCAGCTCTTGGAACTGGATTTGCTTGTTCCAG CAAAAATGAAATGGCTTTAGTGCAAGAATTAGGCGTATCTCCAGAAAACATCATTTATACAAGTCCTTGTAAGCAAGCATCTCAGATAAAGTACGCAGCAAAAGTTGGAGTAAATATTATGACATGTG ACAATGAAGTTGAATTAAAGAAAATTGCGAGGAATCACCCAAATGCCAAGGTCTTACTACATATTGCAACAGAAGATAATATTGGAGGTGAAGATGGTAATATGAAGTTTGGCACTACACTGAAGAAC TGTAGGCATCTTTTGGAATGTGCCAAGGAACTTGATGTCCAAATAATTGGGGTTAAATTTCATATTTCAAGTGCTTGCAAAGAATATCAAGTCTATGTCCATGCCCTGTCTGATGCTCGATGTGTGTT TGACATGGCTGGGGAGTTTGGCTTTACAATGAACATGTTAGACATCGGTGGAGGCTTCACAGGAACTGAAATTCAGTTGGAAGAGGTTAATCATGTTATCAGTCCTCTGTTGGATATTTACTTCCCTG AAGGATCTGGCATTCAGATCATTTCCGAACCTGGAAGCTACTATGTATCTTCTGCATTTACGCTTGCAGTCAATATTATTGCTAAGAAAGTTGTTGAAAATGATAAATTATCCTCTGGAGTAGAAAAA AATGGGAGTGACGAGCCAGCCTTCGTGTACTACATGAATGACGGTGTTTATGGTTCTTTTGCAAGTAAGCTTTCTGAGGACTTAAATACTGTTCCAGAGGTTCACAAGAAATACAAGGAAGATGAGCC TCTGTTTACAAGCAGCCTTTGGGGTCCATCCTGTGACGAGCTTGATCAAATTGTGGAAAGTTGTCTTCTTCCTGAGCTGAGCGTGGGAGATTGGCTTATCTTTGATAACATGGGAGCAGATTCTTTGC ACGGACCGTCTGCTTTTAGTGACACTCAGAGGCCAGCTATTTATTTCATGATGTCACTCAGTGATTGGTATGAGATGCAAGATGCTGGAATTACTTCAGATGCAATGATGAAAAACTTCTTCTTTGCA CCCTCTTGCATTCAGCTGAGCCAAGAAGACAACTTCTCCACTGAAGCTTAAACAGGCATTAACGCTTCTTTAGATCTGAAGTCGCAGGTTAAGCTTGTCTGGTCTACATTCCAGTGTGGGGAAAAATT CAATCAATCTTTATTCTGTTAATTTTCTTGGAAACAAATTCATAGTAATAGCTGTTTGGGACCAGACAAAATCAGCTTTCATCTATAATTCATTGGGGGTAATAGGGGATTTATTTAGATAATGTATC CAGATTTAAACATACCAGTTTGACCCACCCCTTAAGCGTTTAAAATAAAATATGCAACAAAATGGATGACTTAGTGGAGATGGAAGCCCATTAATTGGGTTCCCCATCAAATCGTTTACATACAAGTA CACAGTTTTTATAATAAGGATTCCTGTTAAAAGTCTTGTAAAGTTGATGTCTTTCACCCAGATCTATCACATGTGAGTGGAAGACCAGTGTGACTTCATTAGATACGTTTAGTGTATTTAGAGTGTGT AAATTTGTGCTTTGGACTGTAGTTTAATAAATGTAAAATTGCATCATAGTATTTGTTGTATTTGACCTAATGTAACCTTGTATGATTGCAATAAAACTTTGTGTAGATTTTACCATTTTTTCAGGCTA AAAATTTGGGAATGGGGCTAGCTAGCAAAGGTAGTTTTGAACTAGTTGTGTGTATGGTCTGTTTTGAGAGTTTTCTTTATAGTCCATTTGTTTGGTTTGGCTCAATATACTTTTTAGTTATTTAATTA GTAATTTAAGTAAAAAGTGTTTGGTAATCATTGTGAAGTTCAGATTCATTATGGAGAGTCGATGTGCAGTAAGCATGATGTTTAACAATTTTAACACCAGAAAATGTTAATCTTGCATAAACCAATTG TAATAATAATAGGTGTTTCTGTATAGATAGGATGCATAGAGTACCTTAGTAAATCTTTGAATCACAAATCTTTTGGCTGATAGAAAAGATTTTATTAAACACTGAAAACTTGGTCGGGGATGGGGAGA GAGACTGCAGAAGACTGCAGAACCCTAACCTTAAAGAAGGGCTATGTCTATTTCCAGCATCCTGATGCCCCTTCGCACAGACATTTAAATCGAGAGGGCTTTGGGGTGGTGAAGCACACTCTTCAATT TCTCACTTGTAATGGTATCAAATTGCAATTTTTTTGTTGTTGCTGATCTTGGTTTGAACCTAGTCCCTTAGTTTCTTGTTAATTCCCATTTGTTCAAGCTTAGTAATTCTTCCTTCGTACTAAAGCTT GGTGGGGGGTGGGGGGAGGAGTTAGCTTCACTAACCTGACACTGTTGCCAGGAATTTTGGCTTTGTTCACTGCTAGTGTGTTAGTCCTAAGTCTCAGAATCACAGAAGTAATGAGACAACTTACAGGG GTCACTTTTCCTACCTTACTCTATGTTCACAAGTGGAATTCCTGACCTCCAAGAGGAAATGTGACTTCACTTTGGTGCCAATGGACAGGAAATTCTACCTGTGCTACATAGGAGAAGTGTGGGATACA CTTGAATAGCTGGATTTTACACCTTGATTTCAAGGTGGAAAGAAATTGATCATGAATCTCTAATTTCAAATCAAACCAGTAGGTGCTTAATATTTTTGATTTGAATATTGCCCACTTGAATATCATGG GTTCTATTAATTATAAGAACAACTAAGGACCCCAGTCCACTGTCATCTAGTTGCCCTTGGACTTTTTTCCAAGGTATACTATGGGGTTTATGCAAAATTTGAAGCTACCATATGCATTGTTGTGGTCC AGGAATGCCAAAACTTAAAGCGTGGTACAACCTGAGTCCTTGGCCTGACTGTACAGGCGTGGTCTCTGTGGCATCAGTTTTGCCTTCTGCATAGGAGAAAGGTTGTATGTAACACAGCCCGGAATTGC TATCTCACATGTGAATGATAGGTAAACATAAGAATGTCTGTATTGTTTTTGAAGACTGTTTGCCATAAATCTAAAGTCAAACCTATGTATTTCAATTTGGTATGCTTAAGAATAATTAATGTAAAATC TTTTTATATGATATTGTAATCTCAGTTCAAATTTAATTGCAAATATAAAACCCAAATGATTTCTATATATAGTAAATTGAACTGTCAAGGTAACTTGTGTGTGATTCTGAATACACAGATACAATGTT TTTATTCCTCATGCTTTACTTTGATGGCTTCTATCATGAAATAGATGTGAAATTTTATGAATTAATTCTGTGTATACTGCCCACATTCTT
hide sequence
RefSeq Acc Id:
NM_022585 ⟹ NP_072107
RefSeq Status:
REVIEWED
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 7 71,539,711 - 71,566,515 (-) NCBI mRatBN7.2 7 69,654,773 - 69,681,578 (-) NCBI Rnor_6.0 7 77,345,646 - 77,372,398 (-) NCBI Rnor_5.0 7 77,448,669 - 77,475,344 (-) NCBI RGSC_v3.4 7 74,159,130 - 74,189,447 (-) RGD Celera 7 66,713,070 - 66,739,866 (-) NCBI
Sequence:
AATATAAATACTGGCGTCTCCGGCGCCGCCTTCCCACACTCTCTGGCTCAACTCTCGGCCGCGGTGTTTCCGTTTCTCTCCCTGGTTGTCGCCTGCTCTGCTCTTCTCATCCTTCTCGCTCTGCTGCT CTGCGGAGTGACGAGGCTGAATCTTCTCCCCACCCAGTTCGCGCTTTTCTTCTTTTTCTCGCGCCGCTCCATTTCTCCAGTCCGGCTGCCGCCGCCACTGCTGCTCAGCTGGTGTCGGTGCCGCGCGT TTCCCCCACGTCGTCCCCGCAGCCTATGGCCCAGGCCGCCTTGGGTATTTCTGCTCAAGGTAACCACATCCCTCTTTAAAAATTCCGCCGAAAAAGAGAAGACGCTTTACCCGACTCTTTGGGCCGTT ATCTCACGGCGAACTTTCTGACCGAGTATACAACTACCCAGAAGGCCTAGGAGAAGTGCTGTATAGAGAGCAGTTCGATTTTAACGCTGAGCCACCTTGGGAACCTAGCTGATGATAGGGGGGTTCCA TCTCCTAACTTGTCCATGGAGGTCTTCACTTCAGAAACCCAAGACTCACATTCATCCAGCTTGGTGTCAAGTGGGCTGTTGCTGCCAGGATTATCTTGTGATTATATGAAAGATGTATCAGTTTCTTC TGAAGTGCAGTCAACTGTAGAAGCCTTTGTAGCAGGTGTGTAACAAGTTTGTTGCATATTCTAAGGACCCAGACATAGGCTTGGTGGCCCGTCTCTTGTTTTTCCTGGTTTATGACTTTCGGCTTTGT GGAATACGGCTGAGATGAAAGGATTTATTGACGATGCAAACTACTCCGTTGGCCTGTTGGATGAAGGAACAAACCTTGGAAATGTTATTGATAACTATGTTTATGAACATACCCTGACAGGAAAAAAT GCATTTTTTGTGGGGGATCTTGGGAAGATCGTGAAGAAGCACAGTCAGTGGCAGAACGTGGTGGCTCAGATAAAGCCATTTTACATGGTGAAGTGCAACTCCACTCCAGCCGTACTGGAGATCTTGGC AGCTCTTGGAACTGGATTTGCTTGTTCCAGCAAAAATGAAATGGCTTTAGTGCAAGAATTAGGCGTATCTCCAGAAAACATCATTTATACAAGTCCTTGTAAGCAAGCATCTCAGATAAAGTACGCAG CAAAAGTTGGAGTAAATATTATGACATGTGACAATGAAGTTGAATTAAAGAAAATTGCGAGGAATCACCCAAATGCCAAGGTCTTACTACATATTGCAACAGAAGATAATATTGGAGGTGAAGATGGT AATATGAAGTTTGGCACTACACTGAAGAACTGTAGGCATCTTTTGGAATGTGCCAAGGAACTTGATGTCCAAATAATTGGGGTTAAATTTCATATTTCAAGTGCTTGCAAAGAATATCAAGTCTATGT CCATGCCCTGTCTGATGCTCGATGTGTGTTTGACATGGCTGGGGAGTTTGGCTTTACAATGAACATGTTAGACATCGGTGGAGGCTTCACAGGAACTGAAATTCAGTTGGAAGAGGTTAATCATGTTA TCAGTCCTCTGTTGGATATTTACTTCCCTGAAGGATCTGGCATTCAGATCATTTCCGAACCTGGAAGCTACTATGTATCTTCTGCATTTACGCTTGCAGTCAATATTATTGCTAAGAAAGTTGTTGAA AATGATAAATTATCCTCTGGAGTAGAAAAAAATGGGAGTGACGAGCCAGCCTTCGTGTACTACATGAATGACGGTGTTTATGGTTCTTTTGCAAGTAAGCTTTCTGAGGACTTAAATACTGTTCCAGA GGTTCACAAGAAATACAAGGAAGATGAGCCTCTGTTTACAAGCAGCCTTTGGGGTCCATCCTGTGACGAGCTTGATCAAATTGTGGAAAGTTGTCTTCTTCCTGAGCTGAGCGTGGGAGATTGGCTTA TCTTTGATAACATGGGAGCAGATTCTTTGCACGGACCGTCTGCTTTTAGTGACACTCAGAGGCCAGCTATTTATTTCATGATGTCACTCAGTGATTGGTATGAGATGCAAGATGCTGGAATTACTTCA GATGCAATGATGAAAAACTTCTTCTTTGCACCCTCTTGCATTCAGCTGAGCCAAGAAGACAACTTCTCCACTGAAGCTTAAACAGGCATTAACGCTTCTTTAGATCTGAAGTCGCAGGTTAAGCTTGT CTGGTCTACATTCCAGTGTGGGGAAAAATTCAATCAATCTTTATTCTGTTAATTTTCTTGGAAACAAATTCATAGTAATAGCTGTTTGGGACCAGACAAAATCAGCTTTCATCTATAATTCATTGGGG GTAATAGGGGATTTATTTAGATAATGTATCCAGATTTAAACATACCAGTTTGACCCACCCCTTAAGCGTTTAAAATAAAATATGCAACAAAATGGATGACTTAGTGGAGATGGAAGCCCATTAATTGG GTTCCCCATCAAATCGTTTACATACAAGTACACAGTTTTTATAATAAGGATTCCTGTTAAAAGTCTTGTAAAGTTGATGTCTTTCACCCAGATCTATCACATGTGAGTGGAAGACCAGTGTGACTTCA TTAGATACGTTTAGTGTATTTAGAGTGTGTAAATTTGTGCTTTGGACTGTAGTTTAATAAATGTAAAATTGCATCATAGTATTTGTTGTATTTGACCTAATGTAACCTTGTATGATTGCAATAAAACT TTGTGTAGATTTTACCATTTTTTCAGGCTAAAAATTTGGGAATGGGGCTAGCTAGCAAAGGTAGTTTTGAACTAGTTGTGTGTATGGTCTGTTTTGAGAGTTTTCTTTATAGTCCATTTGTTTGGTTT GGCTCAATATACTTTTTAGTTATTTAATTAGTAATTTAAGTAAAAAGTGTTTGGTAATCATTGTGAAGTTCAGATTCATTATGGAGAGTCGATGTGCAGTAAGCATGATGTTTAACAATTTTAACACC AGAAAATGTTAATCTTGCATAAACCAATTGTAATAATAATAGGTGTTTCTGTATAGATAGGATGCATAGAGTACCTTAGTAAATCTTTGAATCACAAATCTTTTGGCTGATAGAAAAGATTTTATTAA ACACTGAAAACTTGGTCGGGGATGGGGAGAGAGACTGCAGAAGACTGCAGAACCCTAACCTTAAAGAAGGGCTATGTCTATTTCCAGCATCCTGATGCCCCTTCGCACAGACATTTAAATCGAGAGGG CTTTGGGGTGGTGAAGCACACTCTTCAATTTCTCACTTGTAATGGTATCAAATTGCAATTTTTTTGTTGTTGCTGATCTTGGTTTGAACCTAGTCCCTTAGTTTCTTGTTAATTCCCATTTGTTCAAG CTTAGTAATTCTTCCTTCGTACTAAAGCTTGGTGGGGGGTGGGGGGAGGAGTTAGCTTCACTAACCTGACACTGTTGCCAGGAATTTTGGCTTTGTTCACTGCTAGTGTGTTAGTCCTAAGTCTCAGA ATCACAGAAGTAATGAGACAACTTACAGGGGTCACTTTTCCTACCTTACTCTATGTTCACAAGTGGAATTCCTGACCTCCAAGAGGAAATGTGACTTCACTTTGGTGCCAATGGACAGGAAATTCTAC CTGTGCTACATAGGAGAAGTGTGGGATACACTTGAATAGCTGGATTTTACACCTTGATTTCAAGGTGGAAAGAAATTGATCATGAATCTCTAATTTCAAATCAAACCAGTAGGTGCTTAATATTTTTG ATTTGAATATTGCCCACTTGAATATCATGGGTTCTATTAATTATAAGAACAACTAAGGACCCCAGTCCACTGTCATCTAGTTGCCCTTGGACTTTTTTCCAAGGTATACTATGGGGTTTATGCAAAAT TTGAAGCTACCATATGCATTGTTGTGGTCCAGGAATGCCAAAACTTAAAGCGTGGTACAACCTGAGTCCTTGGCCTGACTGTACAGGCGTGGTCTCTGTGGCATCAGTTTTGCCTTCTGCATAGGAGA AAGGTTGTATGTAACACAGCCCGGAATTGCTATCTCACATGTGAATGATAGGTAAACATAAGAATGTCTGTATTGTTTTTGAAGACTGTTTGCCATAAATCTAAAGTCAAACCTATGTATTTCAATTT GGTATGCTTAAGAATAATTAATGTAAAATCTTTTTATATGATATTGTAATCTCAGTTCAAATTTAATTGCAAATATAAAACCCAAATGATTTCTATATATAGTAAATTGAACTGTCAAGGTAACTTGT GTGTGATTCTGAATACACAGATACAATGTTTTTATTCCTCATGCTTTACTTTGATGGCTTCTATCATGAAATAGATGTGAAATTTTATGAATTAATTCTGTGTATACTGCCCACATTCTT
hide sequence
RefSeq Acc Id:
XM_006241568 ⟹ XP_006241630
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 7 71,539,736 - 71,566,265 (-) NCBI mRatBN7.2 7 69,654,798 - 69,681,573 (-) NCBI Rnor_6.0 7 77,345,671 - 77,372,393 (-) NCBI Rnor_5.0 7 77,448,669 - 77,475,344 (-) NCBI
Sequence:
AAATACTGGCGTCTCCGGCGCCGCCTTCCCACACTCTCTGGCTCAACTCTCGGCCGCGGTGTTTCCGTTTCTCTCCCTGGTTGTCGCCTGCTCTGCTCTTCTCATCCTTCTCGCTCTGCTGCTCTGCG GAGTGACGAGGCTGAATCTTCTCCCCACCCAGTTCGCGCTTTTCTTCTTTTTCTCGCGCCGCTCCATTTCTCCAGTCCGGCTGCCGCCGCCACTGCTGCTCAGCTGGTGTCGGTGCCGCGCGTTTCCC CCACGTCGTCCCCGCAGCCTATGGCCCAGGCCGCCTTGGGTATTTCTGCTCAAGGTAACCACATCCCTCTTTAAAAATTCCGCCGAAAAAGAGAAGACGCTTTACCCGACTCTTTGGGCCGTTATCTC ACGGCGAACTTTCTGACCGAGTATACAACTACCCAGAAGGCCTAGGAGAAGTGCTGTATAGAGAGCAGTTCGATTTTAACGCTGAGCCACCTTGGGAACCTAGCTGATGATAGGGGGGTTCCATCTCC TAACTTGTCCATGGAGGTCTTCACTTCAGAAACCCAAGACTCACATTCATCCAGCTTGGTGTCAAGTGGGCTGTTGCTGCCAGGATTATCTTGTGATTATATGAAAGATGTATCAGTTTCTTCTGAAG TGCAGTCAACTGTAGAAGCCTTTGTAGCAGTTTGTTGCATATTCTAAGGACCCAGACATAGGCTTGGTGGCCCGTCTCTTGTTTTTCCTGGTTTATGACTTTCGGCTTTGTGGAATACGGCTGAGATG AAAGGATTTATTGACGATGCAAACTACTCCGTTGGCCTGTTGGATGAAGGAACAAACCTTGGAAATGTTATTGATAACTATGTTTATGAACATACCCTGACAGGAAAAAATGCATTTTTTGTGGGGGA TCTTGGGAAGATCGTGAAGAAGCACAGTCAGTGGCAGAACGTGGTGGCTCAGATAAAGCCATTTTACATGGTGAAGTGCAACTCCACTCCAGCCGTACTGGAGATCTTGGCAGCTCTTGGAACTGGAT TTGCTTGTTCCAGCAAAAATGAAATGGCTTTAGTGCAAGAATTAGGCGTATCTCCAGAAAACATCATTTATACAAGTCCTTGTAAGCAAGCATCTCAGATAAAGTACGCAGCAAAAGTTGGAGTAAAT ATTATGACATGTGACAATGAAGTTGAATTAAAGAAAATTGCGAGGAATCACCCAAATGCCAAGGTCTTACTACATATTGCAACAGAAGATAATATTGGAGGTGAAGATGGTAATATGAAGTTTGGCAC TACACTGAAGAACTGTAGGCATCTTTTGGAATGTGCCAAGGAACTTGATGTCCAAATAATTGGGGTTAAATTTCATATTTCAAGTGCTTGCAAAGAATATCAAGTCTATGTCCATGCCCTGTCTGATG CTCGATGTGTGTTTGACATGGCTGGGGAGTTTGGCTTTACAATGAACATGTTAGACATCGGTGGAGGCTTCACAGGAACTGAAATTCAGTTGGAAGAGGTTAATCATGTTATCAGTCCTCTGTTGGAT ATTTACTTCCCTGAAGGATCTGGCATTCAGATCATTTCCGAACCTGGAAGCTACTATGTATCTTCTGCATTTACGCTTGCAGTCAATATTATTGCTAAGAAAGTTGTTGAAAATGATAAATTATCCTC TGGAGTAGAAAAAAATGGGAGTGACGAGCCAGCCTTCGTGTACTACATGAATGACGGTGTTTATGGTTCTTTTGCAAGTAAGCTTTCTGAGGACTTAAATACTGTTCCAGAGGTTCACAAGAAATACA AGGAAGATGAGCCTCTGTTTACAAGCAGCCTTTGGGGTCCATCCTGTGACGAGCTTGATCAAATTGTGGAAAGTTGTCTTCTTCCTGAGCTGAGCGTGGGAGATTGGCTTATCTTTGATAACATGGGA GCAGATTCTTTGCACGGACCGTCTGCTTTTAGTGACACTCAGAGGCCAGCTATTTATTTCATGATGTCACTCAGTGATTGGTATGAGATGCAAGATGCTGGAATTACTTCAGATGCAATGATGAAAAA CTTCTTCTTTGCACCCTCTTGCATTCAGCTGAGCCAAGAAGACAACTTCTCCACTGAAGCTTAAACAGGCATTAACGCTTCTTTAGATCTGAAGTCGCAGGTTAAGCTTGTCTGGTCTACATTCCAGT GTGGGGAAAAATTCAATCAATCTTTATTCTGTTAATTTTCTTGGAAACAAATTCATAGTAATAGCTGTTTGGGACCAGACAAAATCAGCTTTCATCTATAATTCATTGGGGGTAATAGGGGATTTATT TAGATAATGTATCCAGATTTAAACATACCAGTTTGACCCACCCCTTAAGCGTTTAAAATAAAATATGCAACAAAATGGATGACTTAGTGGAGATGGAAGCCCATTAATTGGGTTCCCCATCAAATCGT TTACATACAAGTACACAGTTTTTATAATAAGGATTCCTGTTAAAAGTCTTGTAAAGTTGATGTCTTTCACCCAGATCTATCACATGTGAGTGGAAGACCAGTGTGACTTCATTAGATACGTTTAGTGT ATTTAGAGTGTGTAAATTTGTGCTTTGGACTGTAGTTTAATAAATGTAAAATTGCATCATAGTATTTGTTGTATTTGACCTAATGTAACCTTGTATGATTGCAATAAAACTTTGTGTAGATTTTACCA TTTTTTCAGGCTAAAAATTTGGGAATGGGGCTAGCTAGCAAAGGTAGTTTTGAACTAGTTGTGTGTATGGTCTGTTTTGAGAGTTTTCTTTATAGTCCATTTGTTTGGTTTGGCTCAATATACTTTTT AGTTATTTAATTAGTAATTTAAGTAAAAAGTGTTTGGTAATCATTGTGAAGTTCAGATTCATTATGGAGAGTCGATGTGCAGTAAGCATGATGTTTAACAATTTTAACACCAGAAAATGTTAATCTTG CATAAACCAATTGTAATAATAATAGGTGTTTCTGTATAGATAGGATGCATAGAGTACCTTAGTAAATCTTTGAATCACAAATCTTTTGGCTGATAGAAAAGATTTTATTAAACACTGAAAACTTGGTC GGGGATGGGGAGAGAGACTGCAGAAGACTGCAGAACCCTAACCTTAAAGAAGGGCTATGTCTATTTCCAGCATCCTGATGCCCCTTCGCACAGACATTTAAATCGAGAGGGCTTTGGGGTGGTGAAGC ACACTCTTCAATTTCTCACTTGTAATGGTATCAAATTGCAATTTTTTTGTTGTTGCTGATCTTGGTTTGAACCTAGTCCCTTAGTTTCTTGTTAATTCCCATTTGTTCAAGCTTAGTAATTCTTCCTT CGTACTAAAGCTTGGTGGGGGGTGGGGGGAGGAGTTAGCTTCACTAACCTGACACTGTTGCCAGGAATTTTGGCTTTGTTCACTGCTAGTGTGTTAGTCCTAAGTCTCAGAATCACAGAAGTAATGAG ACAACTTACAGGGGTCACTTTTCCTACCTTACTCTATGTTCACAAGTGGAATTCCTGACCTCCAAGAGGAAATGTGACTTCACTTTGGTGCCAATGGACAGGAAATTCTACCTGTGCTACATAGGAGA AGTGTGGGATACACTTGAATAGCTGGATTTTACACCTTGATTTCAAGGTGGAAAGAAATTGATCATGAATCTCTAATTTCAAATCAAACCAGTAGGTGCTTAATATTTTTGATTTGAATATTGCCCAC TTGAATATCATGGGTTCTATTAATTATAAGAACAACTAAGGACCCCAGTCCACTGTCATCTAGTTGCCCTTGGACTTTTTTCCAAGGTATACTATGGGGTTTATGCAAAATTTGAAGCTACCATATGC ATTGTTGTGGTCCAGGAATGCCAAAACTTAAAGCGTGGTACAACCTGAGTCCTTGGCCTGACTGTACAGGCGTGGTCTCTGTGGCATCAGTTTTGCCTTCTGCATAGGAGAAAGGTTGTATGTAACAC AGCCCGGAATTGCTATCTCACATGTGAATGATAGGTAAACATAAGAATGTCTGTATTGTTTTTGAAGACTGTTTGCCATAAATCTAAAGTCAAACCTATGTATTTCAATTTGGTATGCTTAAGAATAA TTAATGTAAAATCTTTTTATATGATATTGTAATCTCAGTTCAAATTTAATTGCAAATATAAAACCCAAATGATTTCTATATATAGTAAATTGAACTGTCAAGGTAACTTGTGTGTGATTCTGAATACA CAGATACAATGTTTTTATTCCTCATGCTTTACTTTGATGGCTTCTATCATGAAATAGATGTGAAATTTTATGAATTAA
hide sequence
RefSeq Acc Id:
XM_006241569 ⟹ XP_006241631
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 7 71,539,736 - 71,566,265 (-) NCBI mRatBN7.2 7 69,654,798 - 69,681,573 (-) NCBI Rnor_6.0 7 77,345,671 - 77,372,393 (-) NCBI Rnor_5.0 7 77,448,669 - 77,475,344 (-) NCBI
Sequence:
AAATACTGGCGTCTCCGGCGCCGCCTTCCCACACTCTCTGGCTCAACTCTCGGCCGCGGTGTTTCCGTTTCTCTCCCTGGTTGTCGCCTGCTCTGCTCTTCTCATCCTTCTCGCTCTGCTGCTCTGCG GAGTGACGAGGCTGAATCTTCTCCCCACCCAGTTCGCGCTTTTCTTCTTTTTCTCGCGCCGCTCCATTTCTCCAGTCCGGCTGCCGCCGCCACTGCTGCTCAGCTGGTGTCGGTGCCGCGCGTTTCCC CCACGTCGTCCCCGCAGCCTATGGCCCAGGCCGCCTTGGGTATTTCTGCTCAAGGTAACCACATCCCTCTTTAAAAATTCCGCCGAAAAAGAGAAGACGCTTTACCCGACTCTTTGGGCCGTTATCTC ACGGCGAACTTTCTGACCGAGTATACAACTACCCAGAAGGCCTAGGAGAAGTGCTGTATAGAGAGCAGTTCGATTTTAACGCTGAGCCACCTTGGGAACCTAGCTGATGATAGGGGGGTTCCATCTCC TAACTTGTCCATTTTGTTGCATATTCTAAGGACCCAGACATAGGCTTGGTGGCCCGTCTCTTGTTTTTCCTGGTTTATGACTTTCGGCTTTGTGGAATACGGCTGAGATGAAAGGATTTATTGACGAT GCAAACTACTCCGTTGGCCTGTTGGATGAAGGAACAAACCTTGGAAATGTTATTGATAACTATGTTTATGAACATACCCTGACAGGAAAAAATGCATTTTTTGTGGGGGATCTTGGGAAGATCGTGAA GAAGCACAGTCAGTGGCAGAACGTGGTGGCTCAGATAAAGCCATTTTACATGGTGAAGTGCAACTCCACTCCAGCCGTACTGGAGATCTTGGCAGCTCTTGGAACTGGATTTGCTTGTTCCAGCAAAA ATGAAATGGCTTTAGTGCAAGAATTAGGCGTATCTCCAGAAAACATCATTTATACAAGTCCTTGTAAGCAAGCATCTCAGATAAAGTACGCAGCAAAAGTTGGAGTAAATATTATGACATGTGACAAT GAAGTTGAATTAAAGAAAATTGCGAGGAATCACCCAAATGCCAAGGTCTTACTACATATTGCAACAGAAGATAATATTGGAGGTGAAGATGGTAATATGAAGTTTGGCACTACACTGAAGAACTGTAG GCATCTTTTGGAATGTGCCAAGGAACTTGATGTCCAAATAATTGGGGTTAAATTTCATATTTCAAGTGCTTGCAAAGAATATCAAGTCTATGTCCATGCCCTGTCTGATGCTCGATGTGTGTTTGACA TGGCTGGGGAGTTTGGCTTTACAATGAACATGTTAGACATCGGTGGAGGCTTCACAGGAACTGAAATTCAGTTGGAAGAGGTTAATCATGTTATCAGTCCTCTGTTGGATATTTACTTCCCTGAAGGA TCTGGCATTCAGATCATTTCCGAACCTGGAAGCTACTATGTATCTTCTGCATTTACGCTTGCAGTCAATATTATTGCTAAGAAAGTTGTTGAAAATGATAAATTATCCTCTGGAGAAAAAAATGGGAG TGACGAGCCAGCCTTCGTGTACTACATGAATGACGGTGTTTATGGTTCTTTTGCAAGTAAGCTTTCTGAGGACTTAAATACTGTTCCAGAGGTTCACAAGAAATACAAGGAAGATGAGCCTCTGTTTA CAAGCAGCCTTTGGGGTCCATCCTGTGACGAGCTTGATCAAATTGTGGAAAGTTGTCTTCTTCCTGAGCTGAGCGTGGGAGATTGGCTTATCTTTGATAACATGGGAGCAGATTCTTTGCACGGACCG TCTGCTTTTAGTGACACTCAGAGGCCAGCTATTTATTTCATGATGTCACTCAGTGATTGGTATGAGATGCAAGATGCTGGAATTACTTCAGATGCAATGATGAAAAACTTCTTCTTTGCACCCTCTTG CATTCAGCTGAGCCAAGAAGACAACTTCTCCACTGAAGCTTAAACAGGCATTAACGCTTCTTTAGATCTGAAGTCGCAGGTTAAGCTTGTCTGGTCTACATTCCAGTGTGGGGAAAAATTCAATCAAT CTTTATTCTGTTAATTTTCTTGGAAACAAATTCATAGTAATAGCTGTTTGGGACCAGACAAAATCAGCTTTCATCTATAATTCATTGGGGGTAATAGGGGATTTATTTAGATAATGTATCCAGATTTA AACATACCAGTTTGACCCACCCCTTAAGCGTTTAAAATAAAATATGCAACAAAATGGATGACTTAGTGGAGATGGAAGCCCATTAATTGGGTTCCCCATCAAATCGTTTACATACAAGTACACAGTTT TTATAATAAGGATTCCTGTTAAAAGTCTTGTAAAGTTGATGTCTTTCACCCAGATCTATCACATGTGAGTGGAAGACCAGTGTGACTTCATTAGATACGTTTAGTGTATTTAGAGTGTGTAAATTTGT GCTTTGGACTGTAGTTTAATAAATGTAAAATTGCATCATAGTATTTGTTGTATTTGACCTAATGTAACCTTGTATGATTGCAATAAAACTTTGTGTAGATTTTACCATTTTTTCAGGCTAAAAATTTG GGAATGGGGCTAGCTAGCAAAGGTAGTTTTGAACTAGTTGTGTGTATGGTCTGTTTTGAGAGTTTTCTTTATAGTCCATTTGTTTGGTTTGGCTCAATATACTTTTTAGTTATTTAATTAGTAATTTA AGTAAAAAGTGTTTGGTAATCATTGTGAAGTTCAGATTCATTATGGAGAGTCGATGTGCAGTAAGCATGATGTTTAACAATTTTAACACCAGAAAATGTTAATCTTGCATAAACCAATTGTAATAATA ATAGGTGTTTCTGTATAGATAGGATGCATAGAGTACCTTAGTAAATCTTTGAATCACAAATCTTTTGGCTGATAGAAAAGATTTTATTAAACACTGAAAACTTGGTCGGGGATGGGGAGAGAGACTGC AGAAGACTGCAGAACCCTAACCTTAAAGAAGGGCTATGTCTATTTCCAGCATCCTGATGCCCCTTCGCACAGACATTTAAATCGAGAGGGCTTTGGGGTGGTGAAGCACACTCTTCAATTTCTCACTT GTAATGGTATCAAATTGCAATTTTTTTGTTGTTGCTGATCTTGGTTTGAACCTAGTCCCTTAGTTTCTTGTTAATTCCCATTTGTTCAAGCTTAGTAATTCTTCCTTCGTACTAAAGCTTGGTGGGGG GTGGGGGGAGGAGTTAGCTTCACTAACCTGACACTGTTGCCAGGAATTTTGGCTTTGTTCACTGCTAGTGTGTTAGTCCTAAGTCTCAGAATCACAGAAGTAATGAGACAACTTACAGGGGTCACTTT TCCTACCTTACTCTATGTTCACAAGTGGAATTCCTGACCTCCAAGAGGAAATGTGACTTCACTTTGGTGCCAATGGACAGGAAATTCTACCTGTGCTACATAGGAGAAGTGTGGGATACACTTGAATA GCTGGATTTTACACCTTGATTTCAAGGTGGAAAGAAATTGATCATGAATCTCTAATTTCAAATCAAACCAGTAGGTGCTTAATATTTTTGATTTGAATATTGCCCACTTGAATATCATGGGTTCTATT AATTATAAGAACAACTAAGGACCCCAGTCCACTGTCATCTAGTTGCCCTTGGACTTTTTTCCAAGGTATACTATGGGGTTTATGCAAAATTTGAAGCTACCATATGCATTGTTGTGGTCCAGGAATGC CAAAACTTAAAGCGTGGTACAACCTGAGTCCTTGGCCTGACTGTACAGGCGTGGTCTCTGTGGCATCAGTTTTGCCTTCTGCATAGGAGAAAGGTTGTATGTAACACAGCCCGGAATTGCTATCTCAC ATGTGAATGATAGGTAAACATAAGAATGTCTGTATTGTTTTTGAAGACTGTTTGCCATAAATCTAAAGTCAAACCTATGTATTTCAATTTGGTATGCTTAAGAATAATTAATGTAAAATCTTTTTATA TGATATTGTAATCTCAGTTCAAATTTAATTGCAAATATAAAACCCAAATGATTTCTATATATAGTAAATTGAACTGTCAAGGTAACTTGTGTGTGATTCTGAATACACAGATACAATGTTTTTATTCC TCATGCTTTACTTTGATGGCTTCTATCATGAAATAGATGTGAAATTTTATGAATTAA
hide sequence
RefSeq Acc Id:
XM_017595068 ⟹ XP_017450557
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 7 71,539,736 - 71,551,907 (-) NCBI mRatBN7.2 7 69,654,798 - 69,666,970 (-) NCBI Rnor_6.0 7 77,345,671 - 77,358,161 (-) NCBI
Sequence:
GTTTGTTGCATATTCTAAGGACCCAGACATAGGCTTGGTGGCCCGTCTCTTGTTTTTCCTGGTT TATGACTTTCGGCTTTGTGGAATACGGCTGAGATGAAAGGATTTATTGACGATGCAAACTACTCCGTTGGCCTGTTGGATGAAGGAACAAACCTTGGAAATGTTATTGATAACTATGTTTATGAACAT ACCCTGACAGGAAAAAATGCATTTTTTGTGGGGGATCTTGGGAAGATCGTGAAGAAGCACAGTCAGTGGCAGAACGTGGTGGCTCAGATAAAGCCATTTTACATGGTGAAGTGCAACTCCACTCCAGC CGTACTGGAGATCTTGGCAGCTCTTGGAACTGGATTTGCTTGTTCCAGCAAAAATGAAATGGCTTTAGTGCAAGAATTAGGCGTATCTCCAGAAAACATCATTTATACAAGTCCTTGTAAGCAAGCAT CTCAGATAAAGTACGCAGCAAAAGTTGGAGTAAATATTATGACATGTGACAATGAAGTTGAATTAAAGAAAATTGCGAGGAATCACCCAAATGCCAAGGTCTTACTACATATTGCAACAGAAGATAAT ATTGGAGGTGAAGATGGTAATATGAAGTTTGGCACTACACTGAAGAACTGTAGGCATCTTTTGGAATGTGCCAAGGAACTTGATGTCCAAATAATTGGGGTTAAATTTCATATTTCAAGTGCTTGCAA AGAATATCAAGTCTATGTCCATGCCCTGTCTGATGCTCGATGTGTGTTTGACATGGCTGGGGAGTTTGGCTTTACAATGAACATGTTAGACATCGGTGGAGGCTTCACAGGAACTGAAATTCAGTTGG AAGAGGTTAATCATGTTATCAGTCCTCTGTTGGATATTTACTTCCCTGAAGGATCTGGCATTCAGATCATTTCCGAACCTGGAAGCTACTATGTATCTTCTGCATTTACGCTTGCAGTCAATATTATT GCTAAGAAAGTTGTTGAAAATGATAAATTATCCTCTGGAGTAGAAAAAAATGGGAGTGACGAGCCAGCCTTCGTGTACTACATGAATGACGGTGTTTATGGTTCTTTTGCAAGTAAGCTTTCTGAGGA CTTAAATACTGTTCCAGAGGTTCACAAGAAATACAAGGAAGATGAGCCTCTGTTTACAAGCAGCCTTTGGGGTCCATCCTGTGACGAGCTTGATCAAATTGTGGAAAGTTGTCTTCTTCCTGAGCTGA GCGTGGGAGATTGGCTTATCTTTGATAACATGGGAGCAGATTCTTTGCACGGACCGTCTGCTTTTAGTGACACTCAGAGGCCAGCTATTTATTTCATGATGTCACTCAGTGATTGGTATGAGATGCAA GATGCTGGAATTACTTCAGATGCAATGATGAAAAACTTCTTCTTTGCACCCTCTTGCATTCAGCTGAGCCAAGAAGACAACTTCTCCACTGAAGCTTAAACAGGCATTAACGCTTCTTTAGATCTGAA GTCGCAGGTTAAGCTTGTCTGGTCTACATTCCAGTGTGGGGAAAAATTCAATCAATCTTTATTCTGTTAATTTTCTTGGAAACAAATTCATAGTAATAGCTGTTTGGGACCAGACAAAATCAGCTTTC ATCTATAATTCATTGGGGGTAATAGGGGATTTATTTAGATAATGTATCCAGATTTAAACATACCAGTTTGACCCACCCCTTAAGCGTTTAAAATAAAATATGCAACAAAATGGATGACTTAGTGGAGA TGGAAGCCCATTAATTGGGTTCCCCATCAAATCGTTTACATACAAGTACACAGTTTTTATAATAAGGATTCCTGTTAAAAGTCTTGTAAAGTTGATGTCTTTCACCCAGATCTATCACATGTGAGTGG AAGACCAGTGTGACTTCATTAGATACGTTTAGTGTATTTAGAGTGTGTAAATTTGTGCTTTGGACTGTAGTTTAATAAATGTAAAATTGCATCATAGTATTTGTTGTATTTGACCTAATGTAACCTTG TATGATTGCAATAAAACTTTGTGTAGATTTTACCATTTTTTCAGGCTAAAAATTTGGGAATGGGGCTAGCTAGCAAAGGTAGTTTTGAACTAGTTGTGTGTATGGTCTGTTTTGAGAGTTTTCTTTAT AGTCCATTTGTTTGGTTTGGCTCAATATACTTTTTAGTTATTTAATTAGTAATTTAAGTAAAAAGTGTTTGGTAATCATTGTGAAGTTCAGATTCATTATGGAGAGTCGATGTGCAGTAAGCATGATG TTTAACAATTTTAACACCAGAAAATGTTAATCTTGCATAAACCAATTGTAATAATAATAGGTGTTTCTGTATAGATAGGATGCATAGAGTACCTTAGTAAATCTTTGAATCACAAATCTTTTGGCTGA TAGAAAAGATTTTATTAAACACTGAAAACTTGGTCGGGGATGGGGAGAGAGACTGCAGAAGACTGCAGAACCCTAACCTTAAAGAAGGGCTATGTCTATTTCCAGCATCCTGATGCCCCTTCGCACAG ACATTTAAATCGAGAGGGCTTTGGGGTGGTGAAGCACACTCTTCAATTTCTCACTTGTAATGGTATCAAATTGCAATTTTTTTGTTGTTGCTGATCTTGGTTTGAACCTAGTCCCTTAGTTTCTTGTT AATTCCCATTTGTTCAAGCTTAGTAATTCTTCCTTCGTACTAAAGCTTGGTGGGGGGTGGGGGGAGGAGTTAGCTTCACTAACCTGACACTGTTGCCAGGAATTTTGGCTTTGTTCACTGCTAGTGTG TTAGTCCTAAGTCTCAGAATCACAGAAGTAATGAGACAACTTACAGGGGTCACTTTTCCTACCTTACTCTATGTTCACAAGTGGAATTCCTGACCTCCAAGAGGAAATGTGACTTCACTTTGGTGCCA ATGGACAGGAAATTCTACCTGTGCTACATAGGAGAAGTGTGGGATACACTTGAATAGCTGGATTTTACACCTTGATTTCAAGGTGGAAAGAAATTGATCATGAATCTCTAATTTCAAATCAAACCAGT AGGTGCTTAATATTTTTGATTTGAATATTGCCCACTTGAATATCATGGGTTCTATTAATTATAAGAACAACTAAGGACCCCAGTCCACTGTCATCTAGTTGCCCTTGGACTTTTTTCCAAGGTATACT ATGGGGTTTATGCAAAATTTGAAGCTACCATATGCATTGTTGTGGTCCAGGAATGCCAAAACTTAAAGCGTGGTACAACCTGAGTCCTTGGCCTGACTGTACAGGCGTGGTCTCTGTGGCATCAGTTT TGCCTTCTGCATAGGAGAAAGGTTGTATGTAACACAGCCCGGAATTGCTATCTCACATGTGAATGATAGGTAAACATAAGAATGTCTGTATTGTTTTTGAAGACTGTTTGCCATAAATCTAAAGTCAA ACCTATGTATTTCAATTTGGTATGCTTAAGAATAATTAATGTAAAATCTTTTTATATGATATTGTAATCTCAGTTCAAATTTAATTGCAAATATAAAACCCAAATGATTTCTATATATAGTAAATTGA ACTGTCAAGGTAACTTGTGTGTGATTCTGAATACACAGATACAATGTTTTTATTCCTCATGCTTTACTTTGATGGCTTCTATCATGAAATAGATGTGAAATTTTATGAATTAA
hide sequence
RefSeq Acc Id:
XM_063264178 ⟹ XP_063120248
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 7 71,539,736 - 71,566,265 (-) NCBI
RefSeq Acc Id:
NP_072107 ⟸ NM_022585
- UniProtKB:
Q63764 (UniProtKB/Swiss-Prot), Q6P7R3 (UniProtKB/TrEMBL), F7FJZ4 (UniProtKB/TrEMBL)
- Sequence:
MKGFIDDANYSVGLLDEGTNLGNVIDNYVYEHTLTGKNAFFVGDLGKIVKKHSQWQNVVAQIKPFYMVKCNSTPAVLEILAALGTGFACSSKNEMALVQELGVSPENIIYTSPCKQASQIKYAAKVGV NIMTCDNEVELKKIARNHPNAKVLLHIATEDNIGGEDGNMKFGTTLKNCRHLLECAKELDVQIIGVKFHISSACKEYQVYVHALSDARCVFDMAGEFGFTMNMLDIGGGFTGTEIQLEEVNHVISPLL DIYFPEGSGIQIISEPGSYYVSSAFTLAVNIIAKKVVENDKLSSGVEKNGSDEPAFVYYMNDGVYGSFASKLSEDLNTVPEVHKKYKEDEPLFTSSLWGPSCDELDQIVESCLLPELSVGDWLIFDNM GADSLHGPSAFSDTQRPAIYFMMSLSDWYEMQDAGITSDAMMKNFFFAPSCIQLSQEDNFSTEA
hide sequence
RefSeq Acc Id:
XP_006241631 ⟸ XM_006241569
- Peptide Label:
isoform X2
- UniProtKB:
Q63764 (UniProtKB/Swiss-Prot), A0A0G2JW87 (UniProtKB/TrEMBL)
- Sequence:
MKGFIDDANYSVGLLDEGTNLGNVIDNYVYEHTLTGKNAFFVGDLGKIVKKHSQWQNVVAQIKP FYMVKCNSTPAVLEILAALGTGFACSSKNEMALVQELGVSPENIIYTSPCKQASQIKYAAKVGVNIMTCDNEVELKKIARNHPNAKVLLHIATEDNIGGEDGNMKFGTTLKNCRHLLECAKELDVQII GVKFHISSACKEYQVYVHALSDARCVFDMAGEFGFTMNMLDIGGGFTGTEIQLEEVNHVISPLLDIYFPEGSGIQIISEPGSYYVSSAFTLAVNIIAKKVVENDKLSSGEKNGSDEPAFVYYMNDGVY GSFASKLSEDLNTVPEVHKKYKEDEPLFTSSLWGPSCDELDQIVESCLLPELSVGDWLIFDNMGADSLHGPSAFSDTQRPAIYFMMSLSDWYEMQDAGITSDAMMKNFFFAPSCIQLSQEDNFSTEA
hide sequence
RefSeq Acc Id:
XP_006241630 ⟸ XM_006241568
- Peptide Label:
isoform X1
- UniProtKB:
Q63764 (UniProtKB/Swiss-Prot), Q6P7R3 (UniProtKB/TrEMBL), F7FJZ4 (UniProtKB/TrEMBL)
- Sequence:
MKGFIDDANYSVGLLDEGTNLGNVIDNYVYEHTLTGKNAFFVGDLGKIVKKHSQWQNVVAQIKPFYMVKCNSTPAVLEILAALGTGFACSSKNEMALVQELGVSPENIIYTSPCKQASQIKYAAKVGV NIMTCDNEVELKKIARNHPNAKVLLHIATEDNIGGEDGNMKFGTTLKNCRHLLECAKELDVQIIGVKFHISSACKEYQVYVHALSDARCVFDMAGEFGFTMNMLDIGGGFTGTEIQLEEVNHVISPLL DIYFPEGSGIQIISEPGSYYVSSAFTLAVNIIAKKVVENDKLSSGVEKNGSDEPAFVYYMNDGVYGSFASKLSEDLNTVPEVHKKYKEDEPLFTSSLWGPSCDELDQIVESCLLPELSVGDWLIFDNM GADSLHGPSAFSDTQRPAIYFMMSLSDWYEMQDAGITSDAMMKNFFFAPSCIQLSQEDNFSTEA
hide sequence
RefSeq Acc Id:
NP_001288631 ⟸ NM_001301702
- UniProtKB:
Q63764 (UniProtKB/Swiss-Prot), Q6P7R3 (UniProtKB/TrEMBL), F7FJZ4 (UniProtKB/TrEMBL)
- Sequence:
MKGFIDDANYSVGLLDEGTNLGNVIDNYVYEHTLTGKNAFFVGDLGKIVKKHSQWQNVVAQIKP FYMVKCNSTPAVLEILAALGTGFACSSKNEMALVQELGVSPENIIYTSPCKQASQIKYAAKVGVNIMTCDNEVELKKIARNHPNAKVLLHIATEDNIGGEDGNMKFGTTLKNCRHLLECAKELDVQII GVKFHISSACKEYQVYVHALSDARCVFDMAGEFGFTMNMLDIGGGFTGTEIQLEEVNHVISPLLDIYFPEGSGIQIISEPGSYYVSSAFTLAVNIIAKKVVENDKLSSGVEKNGSDEPAFVYYMNDGV YGSFASKLSEDLNTVPEVHKKYKEDEPLFTSSLWGPSCDELDQIVESCLLPELSVGDWLIFDNMGADSLHGPSAFSDTQRPAIYFMMSLSDWYEMQDAGITSDAMMKNFFFAPSCIQLSQEDNFSTEA
hide sequence
RefSeq Acc Id:
XP_017450557 ⟸ XM_017595068
- Peptide Label:
isoform X1
- UniProtKB:
Q63764 (UniProtKB/Swiss-Prot), Q6P7R3 (UniProtKB/TrEMBL), F7FJZ4 (UniProtKB/TrEMBL)
- Sequence:
MKGFIDDANYSVGLLDEGTNLGNVIDNYVYEHTLTGKNAFFVGDLGKIVKKHSQWQNVVAQIKPFYMVKCNSTPAVLEILAALGTGFACSSKNEMALVQELGVSPENIIYTSPCKQASQIKYAAKVGV NIMTCDNEVELKKIARNHPNAKVLLHIATEDNIGGEDGNMKFGTTLKNCRHLLECAKELDVQIIGVKFHISSACKEYQVYVHALSDARCVFDMAGEFGFTMNMLDIGGGFTGTEIQLEEVNHVISPLL DIYFPEGSGIQIISEPGSYYVSSAFTLAVNIIAKKVVENDKLSSGVEKNGSDEPAFVYYMNDGVYGSFASKLSEDLNTVPEVHKKYKEDEPLFTSSLWGPSCDELDQIVESCLLPELSVGDWLIFDNM GADSLHGPSAFSDTQRPAIYFMMSLSDWYEMQDAGITSDAMMKNFFFAPSCIQLSQEDNFSTEA
hide sequence
Ensembl Acc Id:
ENSRNOP00000069785 ⟸ ENSRNOT00000079644
Ensembl Acc Id:
ENSRNOP00000007999 ⟸ ENSRNOT00000007999
RefSeq Acc Id:
XP_063120248 ⟸ XM_063264178
- Peptide Label:
isoform X2
- UniProtKB:
Q63764 (UniProtKB/Swiss-Prot), A0A0G2JW87 (UniProtKB/TrEMBL)
RGD ID: 13695302
Promoter ID: EPDNEW_R5827
Type: single initiation site
Name: Azin1_1
Description: antizyme inhibitor 1
SO ACC ID: SO:0000170
Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ )
Experiment Methods: Single-end sequencing.
Position: Rat Assembly Chr Position (strand) Source Rnor_6.0 7 77,372,366 - 77,372,426 EPDNEW
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2006-03-30
Azin1
antizyme inhibitor 1
Oazin
ornithine decarboxylase antizyme inhibitor
Symbol and Name updated
1299863
APPROVED
2004-09-10
Oazin
ornithine decarboxylase antizyme inhibitor
Oazi
ornithine decarboxylase antizyme inhibitor
Symbol updated
1299863
APPROVED
2002-06-10
Oazi
ornithine decarboxylase antizyme inhibitor
Name updated
70584
APPROVED
Note Type
Note
Reference
gene_physical_interaction
binds to the antizyme releasing ornithine decarboxylase from ornithine decarboxylase-antizyme complex
633334